Over 20 years of executive management and Board experience in rapid growth biotech companies. Raised and managed over $100M in equity capital and collaborative R&D funding. Past roles include: CEO and Managing Director of Gordagen Pharmaceuticals Pty Ltd., the Molecular Plant Breeding CRC and Molecular Plant Breeding Pty Ltd., and AgGenomics Pty Ltd. (a subsidiary of Genetic Technologies Limited, ASX:GTG). Fellow of the Australian Institute of Company Directors.
Previously President of MusclePharm Corp where he was responsible for the Company expanding into 50,000 retail outlets and 120 countries along with sales revenue growth from US$67M in 2012 to US$167M in 2015.
Formerly the Medical Director of Roche Australia where he was involved in all product lifecycle phases from phase 1 to 4 including clinical development, regulatory, PBS listing and medical affairs for more than 40 new products.
Steven has extensive experience in mergers and acquisitions, capital raising and cross border transactions with ASX companies. He was also previously the Chief Executive Officer of ASX listed mining company Anchor Resources Ltd (ASX:AHR).
As a practicing lawyer he has worked for Norton Rose Fulbright in Beijing and Melbourne, Deacons and Maddocks Lawyers in Melbourne.
Ian is a Chartered Accountant (CA) with over 20 years’ experience with private and ASX listed public companies. Ian has experience with mature and developing organisations nationally and internationally.
Ian graduated from the University of New England and became a CA in 1998 then worked in business services at BDO and PWC.
Having worked in industry with small start-up companies through to large U.S. and Japanese multinational companies, Ian has broad expertise in all facets of financial management.
Catriona has over 20 years’ experience in private practice providing legal, corporate governance and company secretarial advice to a range of companies including ASX listed companies, private and not-for-profit organisations.